Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $102,070 | 61 | 79.8% |
| Travel and Lodging | $13,701 | 135 | 10.7% |
| Food and Beverage | $9,058 | 203 | 7.1% |
| Consulting Fee | $3,000 | 6 | 2.3% |
| Gift | $50.40 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $109,082 | 270 | $0 (2024) |
| Allergan, Inc. | $14,892 | 61 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $699.21 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $683.63 | 9 | $0 (2022) |
| Integra LifeSciences Corporation | $486.42 | 3 | $0 (2023) |
| Davol Inc. | $227.41 | 2 | $0 (2021) |
| Melinta Therapeutics, Inc. | $199.92 | 3 | $0 (2019) |
| PFIZER INC. | $193.10 | 16 | $0 (2020) |
| Smith+Nephew, Inc. | $171.50 | 2 | $0 (2022) |
| Ethicon US, LLC | $170.46 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,459 | 48 | ABBVIE INC. ($19,031) |
| 2023 | $28,589 | 65 | ABBVIE INC. ($28,100) |
| 2022 | $37,178 | 130 | ABBVIE INC. ($36,311) |
| 2021 | $26,721 | 67 | AbbVie Inc. ($25,640) |
| 2020 | $10,967 | 46 | Allergan, Inc. ($10,701) |
| 2019 | $4,342 | 31 | Allergan Inc. ($3,984) |
| 2018 | $543.05 | 14 | Allergan Inc. ($191.88) |
| 2017 | $80.23 | 5 | Janssen Pharmaceuticals, Inc ($32.85) |
All Payment Transactions
406 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/05/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $119.19 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/05/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/05/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/05/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $9.38 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/05/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/16/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/30/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/23/2024 | Ethicon US, LLC | STRATAFIX (Device) | Food and Beverage | In-kind items and services | $111.37 | General |
| Category: Wound Closure | ||||||
| 09/12/2024 | Ethicon US, LLC | STRATAFIX (Device) | Food and Beverage | In-kind items and services | $36.36 | General |
| Category: Wound Closure | ||||||
| 09/12/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $13.94 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/11/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $186.21 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/11/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $180.90 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/11/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $123.59 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/11/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $54.17 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/11/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $40.41 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/11/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/10/2024 | Ethicon US, LLC | STRATAFIX (Device) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Wound Closure | ||||||
| 08/28/2024 | Abbott Laboratories | I-STAT (Device) | Food and Beverage | In-kind items and services | $84.70 | General |
| Category: Point of Care | ||||||
| 08/28/2024 | Abbott Laboratories | I-STAT (Device) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: Point of Care | ||||||
| 07/02/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/29/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/03/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $137.73 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/03/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $53.57 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/03/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 550 | 566 | $705,555 | $62,138 |
| 2022 | 6 | 660 | 683 | $774,278 | $78,253 |
| 2021 | 6 | 500 | 508 | $566,474 | $57,420 |
| 2020 | 5 | 204 | 207 | $250,102 | $26,604 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 242 | 247 | $429,039 | $37,705 | 8.8% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 112 | 116 | $135,256 | $11,648 | 8.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 55 | 56 | $109,312 | $10,373 | 9.5% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 21 | 26 | $20,332 | $1,582 | 7.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 120 | 121 | $11,616 | $829.86 | 7.1% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 312 | 321 | $557,577 | $57,171 | 10.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 46 | 46 | $89,396 | $10,343 | 11.6% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 71 | 71 | $82,786 | $7,728 | 9.3% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 25 | 31 | $24,242 | $1,553 | 6.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 181 | 189 | $17,952 | $1,323 | 7.4% |
| 93042 | Electrocardiogram (ecg) 1 to 3 leads with review by physician only | Facility | 2022 | 25 | 25 | $2,325 | $135.19 | 5.8% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 209 | 211 | $366,286 | $37,356 | 10.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 40 | 40 | $78,080 | $9,264 | 11.9% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 76 | 76 | $88,616 | $8,241 | 9.3% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 22 | 24 | $18,768 | $1,482 | 7.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 133 | 137 | $12,864 | $964.76 | 7.5% |
| 93042 | Interpretation and report of electrical activity of heart using 1-3 leads | Facility | 2021 | 20 | 20 | $1,860 | $113.24 | 6.1% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 71 | 72 | $118,876 | $12,154 | 10.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 39 | 39 | $70,782 | $8,520 | 12.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 39 | 40 | $43,420 | $4,517 | 10.4% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 19 | 19 | $13,472 | $1,141 | 8.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 36 | 37 | $3,552 | $271.57 | 7.6% |
About Harry Kopolovich, M.D., M.B.A
Harry Kopolovich, M.D., M.B.A is a Emergency Medical Technician, Basic healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1144351156.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Harry Kopolovich, M.D., M.B.A has received a total of $127,880 in payments from pharmaceutical and medical device companies, with $19,459 received in 2024. These payments were reported across 406 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($102,070).
As a Medicare-enrolled provider, Kopolovich has provided services to 1,914 Medicare beneficiaries, totaling 1,964 services with total Medicare billing of $224,415. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Emergency Medical Technician, Basic
- Other Specialties Basic|Critical Access|Emergency Medicine
- Location Bronx, NY
- Active Since 03/08/2007
- Last Updated 12/17/2021
- Taxonomy Code 146N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1144351156
Products in Payments
- DALVANCE (Drug) $115,302
- AVYCAZ (Drug) $6,655
- TEFLARO (Drug) $2,017
- XARELTO (Drug) $699.21
- Integra (Device) $486.42
- LOKELMA (Drug) $465.64
- ANDEXXA (Biological) $246.28
- Phasix (Device) $227.41
- ELIQUIS (Drug) $208.94
- HEALICOIL (Device) $171.50
- STRATAFIX (Device) $170.46
- GIAPREZA (Drug) $125.00
- IGALMI (Drug) $124.09
- Andexxa (Drug) $121.68
- I-STAT (Device) $112.47
- Baxdela (Drug) $108.05
- BRILINTA (Drug) $93.29
- Orbactiv (Drug) $91.87
- FISHER & PAYKEL HEALTHCARE (Device) $88.50
- CLEVIPREX (Drug) $63.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.